American Society of Nephrology (ASN) Kidney Week 2025
Details for the Late-Breaking Clinical Trial Presentation:
| Presentation Title: | Lorundrostat, a Novel Aldosterone Synthase Inhibitor (ASI), in Participants with Uncontrolled Hypertension, CKD, and Albuminuria: Results from Explore-CKD |
| Presenter: | Matthew Weir, MD, Director of the Division of Nephrology at the University of Maryland Medical Center and Professor of Medicine at the University of Maryland School of Medicine |
| Date/Time: | November 7, 2025, from 5:06 PM to 5:18 PM CST |